Canada markets open in 2 hours 1 minute

ESPR Jan 2026 3.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.55000.0000 (0.00%)
As of 02:57PM EDT. Market open.
Full screen
Previous Close0.5500
Open0.9000
Bid0.0000
Ask0.0000
Strike3.00
Expire Date2026-01-16
Day's Range0.5500 - 0.9000
Contract RangeN/A
Volume2
Open Interest155
  • Insider Monkey

    11 Best Low Price Pharma Stocks To Invest In

    In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]

  • GlobeNewswire

    Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

    – Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared to Placebo – – NEXLETOL Demonstrated Clinical Benefit in Historically Underrepresented Groups: Women and Hispanic/Latinx Patients With and Without Cardiovascular Disease (CVD) – – CLEAR Outcomes Sets New Standards for Diversity and Inclusion with Enrollment of 48% Women and 17% Hispanic/Latinx Patients – ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion

  • GlobeNewswire

    Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

    ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m. ET today, April 1, 2024, to commemorate the U.S. Food and Drug Administration’s (FDA) recent approval of broad new labels for Esperion’s products. “We are honored to ring the Nasdaq opening bell to celebrate a significant milestone for Esperion,” said Mr. Koenig. “This ceremony marks an opportunit